AirSculpt Technologies (NASDAQ:AIRS) Major Shareholder Jorey Chernett Purchases 40,000 Shares of Stock

AirSculpt Technologies, Inc. (NASDAQ:AIRS) major shareholder Jorey Chernett purchased 40,000 shares of the stock in a transaction dated Friday, April 17th. The stock was acquired at an average cost of $2.54 per share, with a total value of $101,600.00. Following the transaction, the insider directly owned 7,053,761 shares in the company, valued at approximately $17,916,552.94. This trade represents a 0.57% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at this hyperlink. Major shareholders that own more than 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

Jorey Chernett also recently made the following trade(s):

• On Tuesday, April 14th, Jorey Chernett purchased 20,000 shares of AirSculpt Technologies stock. The stock was acquired at an average cost of $2.60 per share, with a total value of $52,000.00.
• On Tuesday, April 7th, Jorey Chernett purchased 60,000 shares of AirSculpt Technologies stock. The stock was acquired at an average cost of $2.93 per share, with a total value of $175,800.00.
• On Friday, April 3rd, Jorey Chernett purchased 90,000 shares of AirSculpt Technologies stock. The stock was acquired at an average cost of $2.82 per share, with a total value of $253,800.00.
• On Monday, March 23rd, Jorey Chernett purchased 50,000 shares of AirSculpt Technologies stock. The stock was acquired at an average cost of $2.91 per share, with a total value of $145,500.00.
• On Friday, March 20th, Jorey Chernett acquired 40,000 shares of AirSculpt Technologies stock. The shares were bought at an average price of $2.77 per share, with a total value of $110,800.00.
• On Thursday, March 19th, Jorey Chernett acquired 77,702 shares of AirSculpt Technologies stock. The shares were bought at an average price of $2.64 per share, with a total value of $205,133.28.
• On Tuesday, March 17th, Jorey Chernett acquired 83,000 shares of AirSculpt Technologies stock. The shares were bought at an average price of $2.56 per share, with a total value of $212,480.00.
• On Monday, March 16th, Jorey Chernett acquired 105,848 shares of AirSculpt Technologies stock. The shares were bought at an average price of $2.43 per share, with a total value of $257,210.64.
• On Wednesday, March 11th, Jorey Chernett acquired 88,000 shares of AirSculpt Technologies stock. The shares were bought at an average price of $2.15 per share, with a total value of $189,200.00.
• On Friday, March 6th, Jorey Chernett acquired 45,600 shares of AirSculpt Technologies stock. The shares were bought at an average price of $2.00 per share, with a total value of $91,200.00.

AirSculpt Technologies Trading Up 3.1%

Shares of NASDAQ AIRS opened at $2.64 on Tuesday. The company has a debt-to-equity ratio of 0.58, a current ratio of 0.55 and a quick ratio of 0.55. The stock has a market capitalization of $186.25 million, a P/E ratio of -13.89 and a beta of 2.22. AirSculpt Technologies, Inc. has a 1-year low of $1.51 and a 1-year high of $12.00. The business has a fifty day moving average price of $2.37 and a 200 day moving average price of $3.98.

AirSculpt Technologies (NASDAQ:AIRS) last issued its quarterly earnings data on Tuesday, March 31st. The company reported $0.02 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.03) by $0.05. AirSculpt Technologies had a negative return on equity of 5.01% and a negative net margin of 7.68%.The firm had revenue of $33.44 million during the quarter, compared to analysts’ expectations of $34.93 million. During the same period in the prior year, the business posted ($0.09) EPS. The firm’s quarterly revenue was down 14.8% on a year-over-year basis. Equities research analysts expect that AirSculpt Technologies, Inc. will post -0.06 EPS for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the company. BNP Paribas Financial Markets raised its stake in shares of AirSculpt Technologies by 239.5% in the third quarter. BNP Paribas Financial Markets now owns 5,952 shares of the company’s stock worth $48,000 after purchasing an additional 4,199 shares during the last quarter. Wells Fargo & Company MN raised its stake in shares of AirSculpt Technologies by 49.9% in the fourth quarter. Wells Fargo & Company MN now owns 19,275 shares of the company’s stock worth $38,000 after purchasing an additional 6,420 shares during the last quarter. Aigen Investment Management LP purchased a new position in shares of AirSculpt Technologies in the fourth quarter worth about $36,000. Millennium Management LLC purchased a new position in shares of AirSculpt Technologies in the fourth quarter worth about $33,000. Finally, Virtu Financial LLC purchased a new position in shares of AirSculpt Technologies during the fourth quarter worth $30,000. 91.54% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on AIRS. Weiss Ratings reiterated a “sell (d-)” rating on shares of AirSculpt Technologies in a report on Monday, December 29th. Wall Street Zen upgraded AirSculpt Technologies from a “sell” rating to a “hold” rating in a report on Sunday, April 5th. One investment analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, AirSculpt Technologies has an average rating of “Reduce” and a consensus target price of $6.00.

About AirSculpt Technologies

AirSculpt Technologies, Inc (NASDAQ: AIRS) is a medical technology company specializing in minimally invasive body contouring. The company’s flagship AirSculpt® platform combines pneumatic power with precision microcannulas to deliver fat removal, transfer and sculpting procedures. AirSculpt Technologies partners with both company-owned and franchised cosmetic surgery practices to offer a streamlined, office-based alternative to traditional liposuction.

Through its proprietary system, AirSculpt Technologies provides both consumers and medical professionals with an integrated solution that emphasizes reduced downtime, smaller incision sites, and more predictable outcomes.